Pharmaceutical & Life Sciences News

Abbott Wins FDA Approval of Much-Anticipated Insulin-Monitor App

Nov. 1, 2018, 2:53 PM

Abbott Laboratories won U.S. approval for its FreeStyle LibreLink diabetes-monitoring app, giving users a way to keep track of their glucose levels from their iPhones.

The app works with Abbott’s FreeStyle Libre glucose sensors, which have rapidly become some of the top-selling medical devices in the U.S. It is likely to be a welcome addition for millions of customers who currently rely on separate pocket-sized gadgets to read their results. Rivals Medtronic Plc and DexCom Inc. already had smartphone capability for their glucose systems.

The approval of the app by the Food and Drug Administration was announced by Abbott Nov....

To read the full article log in. To learn more about a subscription click here.